These compounds may interact with:
DNA dC->dU-editing enzyme APOBEC-3A
Potentially involved in: urinary bladder cancer; cancer; anogenital venereal wart; psychotic disorders; nonorganic psychosis; mammary neoplasms; juvenile arthritis; atopic dermatitis; chronic lymphosyte leukemia; cutaneous lupus erythematosus; dermatomyositis; interstitial cystitis; juvenile dermatomyositis; lung adenocarcinoma; lung cancer; lung carcinoma; mucosa-associated lymphoid tissue lymphoma; osteosarcoma; psoriasis; tuberculosis
Disease data sourced from Pharos.